全文获取类型
收费全文 | 35940篇 |
免费 | 2357篇 |
国内免费 | 205篇 |
专业分类
耳鼻咽喉 | 326篇 |
儿科学 | 888篇 |
妇产科学 | 732篇 |
基础医学 | 4153篇 |
口腔科学 | 1041篇 |
临床医学 | 3199篇 |
内科学 | 7605篇 |
皮肤病学 | 604篇 |
神经病学 | 2127篇 |
特种医学 | 930篇 |
外国民族医学 | 5篇 |
外科学 | 5557篇 |
综合类 | 1095篇 |
一般理论 | 31篇 |
预防医学 | 2876篇 |
眼科学 | 1210篇 |
药学 | 3493篇 |
中国医学 | 420篇 |
肿瘤学 | 2210篇 |
出版年
2023年 | 352篇 |
2022年 | 916篇 |
2021年 | 1670篇 |
2020年 | 1093篇 |
2019年 | 1347篇 |
2018年 | 1618篇 |
2017年 | 1135篇 |
2016年 | 1108篇 |
2015年 | 1264篇 |
2014年 | 1701篇 |
2013年 | 2007篇 |
2012年 | 2856篇 |
2011年 | 2887篇 |
2010年 | 1688篇 |
2009年 | 1297篇 |
2008年 | 2033篇 |
2007年 | 1922篇 |
2006年 | 1691篇 |
2005年 | 1500篇 |
2004年 | 1293篇 |
2003年 | 1112篇 |
2002年 | 947篇 |
2001年 | 588篇 |
2000年 | 541篇 |
1999年 | 447篇 |
1998年 | 190篇 |
1997年 | 157篇 |
1996年 | 147篇 |
1995年 | 149篇 |
1994年 | 77篇 |
1993年 | 105篇 |
1992年 | 224篇 |
1991年 | 203篇 |
1990年 | 181篇 |
1989年 | 187篇 |
1988年 | 151篇 |
1987年 | 162篇 |
1986年 | 135篇 |
1985年 | 146篇 |
1984年 | 129篇 |
1983年 | 103篇 |
1982年 | 74篇 |
1981年 | 71篇 |
1979年 | 110篇 |
1978年 | 74篇 |
1977年 | 72篇 |
1976年 | 58篇 |
1975年 | 63篇 |
1974年 | 57篇 |
1973年 | 61篇 |
排序方式: 共有10000条查询结果,搜索用时 634 毫秒
991.
Rashid Khan Ashwani K Singal Bhupinderjit S Anand 《World journal of gastroenterology : WJG》2014,20(34):11935-11938
Alcohol abuse and chronic hepatitis C virus(HCV)infection are two major causes of chronic liver disease in the United States.About 10%-15%of liver transplants performed in the United States are for patients with cirrhosis due to combined alcohol and HCV infection.Data on outcomes on graft and patient survival,HCV recurrence,and relapse of alcohol use comparing transplants in hepatitis C positive drinkers compared to alcohol abuse or hepatitis C alone are conflicting in the literature.Some studies report a slightly better overall outcome in patients who were transplanted for alcoholic cirrhosis vs those transplanted for HCV alone or for combined HCV and alcohol related cirrhosis.However,some other studies do not support these observations.However,most studies are limited to a retrospective design or small sample size.Larger prospective multicenter studies are needed to better define the outcomes in hepatitis C drinkers. 相似文献
992.
Nooraldaem Yousif Suddharsan Subbramaniyam Babu Thevan Mohammad Amin Leena Sulaibikh Nazar Bukamal Habib Tareif Sadananda Shivappa Haitham Amin Husam A. Noor 《Journal of the Saudi Heart Association》2020,32(3):434
BACKGROUNDTranscatheter aortic valve implantation (TAVI) is a minimally invasive procedure that is considered a good alternative to surgical aortic valve replacement (sAVR) in selected patients. Our aim is to determine the baseline, procedural characteristics and one-year clinical outcomes of our TAVI registry.METHODSThis study is a retrospective observational analysis of a prospectively designed cohort comprising 81 consecutive patients treated at Mohammed bin Khalifa Cardiac Centre (MKCC) who were enrolled in Bahrain TAVI registry from February 2014 to February 2019. The clinical endpoints were defined according to the updated Valve Academic Research Consortium-2 (VARC-2) consensus document.RESULTSOut of the 81 patients included in our study, there were 37 (45.7%) males. The mean age was 76.4 ± 8.9 years with a mean Logistic European System for Cardiac Operative Risk Evaluation (EuroSCORE II) of 4.1 ± 2.5 and a mean Society of Thoracic Surgery (STS) Risk Score of 4.2 ± 3.5. Evolute-R valve was used for 36 (44.4%) patients, Edward Sapien for 26 patients (32.1%), and Core valve for 19 patients (23.5%). At one year follow up, all-cause death was reported in three (3.7%) patients; none of them was cardiovascular mortality. As per VARC-II criteria, no cases fulfilled the criteria of valve dysfunction but TAVI-related complications (i.e., TAV-in-TAV deployment) were reported in four (4.9%) cases. One (1.2%) case of major bleeding was encountered but no patient experienced life-threatening bleeding. Major vascular complications were documented in two patients (2.5%) only. Significant Acute Kidney Injury (AKI) occurred in two (2.5%) patients, both classified as stage-2 but no one deteriorated to stage-3 or hemodialysis. Seven (8.6%) patients required permanent pacemakers, and all were implanted during the index admission for TAVI. One patient (1.2%) had stroke and all survivors completed one-year follow up.CONCLUSIONThe TAVI program in Bahrain is encouraging and corresponds to the finest international centers outcomes in terms of procedural success and complications rate. 相似文献
993.
994.
995.
996.
997.
998.
999.